Skip to main content

Table 6 Histological scoring means, standard deviations, and Wilcoxon/Kruskal-Wallis results

From: In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility study

Coating group Endothelial cell loss Surface fibrin Neointimal/medial Medial smooth muscle cell loss Medial Adventitial
Score Platelets score Fibrin score Inflammation score Depth Circumference Injury score Inflammation score Fibrosis score
Uncoated (n = 4) 0.08 ± 0.17 0.58 ± 1.17 0.83 ± 1.67 2.50 ± 1.04 0.25 ± 0.50 0.58 ± 1.17 0.42 ± 0.42 0.92 ± 1.26 0.00 ± 0.00
HPC-1 (n = 4) 0.17 ± 0.33 0.50 ± 0.58 0.00 ± 0.00 1.75 ± 0.74 0.00 ± 0.00 0.00 ± 0.00 0.25 ± 0.32 0.25 ± 0.32 1.50 ± 1.82
HPC-2 (n = 4) 0.50 ± 0.64 0.58 ± 0.69 0.33 ± 0.67 2.25 ± 0.57 0.50 ± 0.43 0.83 ± 1.23 0.50 ± 0.43 0.42 ± 0.63 1.50 ± 1.91
HPC-3 (n = 4) 0.25 ± 0.50 0.83 ± 1.26 0.92 ± 1.83 1.58 ± 0.96 0.42 ± 0.32 1.33 ± 1.22 0.58 ± 0.17 1.17 ± 0.88 0.00 ± 0.00
p value 0.731 0.963 0.762 0.384 0.183 0.144 0.514 0.522 0.181